The Institute of Cancer Research, London, has uncovered a promising new treatment target for pancreatic cancer, identifying the protein SPP1 as a ...

Caltech researchers have developed a powerful new method for creating embryo-like structures from stem cells that could transform how we study fertility. Using stem cells rather than a traditional ...

Rocket CRM has introduced a new series of platform enhancements focused on strengthening customer relationship management while integrating social media marketing automation into its core framework.

People with type 1 diabetes must constantly rely on insulin injections or pumps, usually for the rest of their life after diagnosis. The autoimmune disease destroys the cells that produce the hormone, ...

TIPTONVILLE, Tenn. - Cell phone data puts Austin Drummond at the scene of the murders of four West Tennessee family members, according to a special agent with the Tennessee Bureau of Investigation ...

Patients with intermediate stage primary liver cancer who received a vaccine of dendritic cells saw a longer time without tumor progression in response to standard treatment, according to a new study ...

A Pfizer drug designed to address a severe problem associated with sickle cell disease failed to beat a placebo in a Phase 3 clinical trial. It’s the latest setback for Pfizer in this inherited blood ...

The International Energy Agency estimates global electricity demand from data centres to more than double to about 945 TWh – more than the entire electricity consumption of Japan today – by 2030. The ...

A new paper published today in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel synthetic ligand that activates the Notch signaling pathway, a key ...

Cutaneous squamous-cell carcinoma (SCC) is primarily caused by oncogenesis mediated by ultraviolet radiation, and β-human papillomavirus (β-HPV) is believed to be a mere facilitator that is ...

Elegen and Nutcracker Therapeutics launched a pilot program to demonstrate what they label the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer ...